Commentary on meta-analysis of randomized controlled trials for HIV treatment adherence interventions: Research directions and implications for practice

Journal of Acquired Immune Deficiency Syndromes

Volumn 43, Issue SUPPL. 1, 2006, Pages

  Gordon, Christopher M ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Adherence; Antiretroviral therapy; Highly active antiretroviral therapy; HIV AIDS; Interventions; Meta analysis

Indexed keywords

ANTIRETROVIRUS AGENT; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ARTICLE; CLINICAL PRACTICE; CLINICAL RESEARCH; CLINICAL TRIAL; COMMUNITY; DIRECTLY OBSERVED THERAPY; EVIDENCE BASED MEDICINE; GOVERNMENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; META ANALYSIS; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZATION; SYSTEMATIC REVIEW; TREATMENT OUTCOME; VIRUS LOAD;

ANTI-HIV AGENTS; HIV INFECTIONS; HUMANS; INTERNATIONAL COOPERATION; PATIENT COMPLIANCE; PHYSICIAN'S PRACTICE PATTERNS; RANDOMIZED CONTROLLED TRIALS;

EID: 33845356801     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000248347.87512.ba     Document Type: Article

References (33)

1. Panel on Clinical Practices for the Treatment of HIV Infection. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Available at: http://www.aidsinfo.nih.gov/. 2005.
2. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21-30.
3. Maggiolo F, Ravasio L, Ripamonti D, et al. Similar adherence rates favor different virologic outcomes for patients treated with nonnucleoside analogues or protease inhibitors. Clin Infect Dis. 2005;40:158-163.
4. Bangsberg DR, Moss AR, Deeks SG. Paradoxes of adherence and drug resistance to HIV antiretroviral therapy. J Antimicrob Chemother. 2004;53:696-699.
5. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487-497.
6. Margolin A, Avants SK, Warburton LA, et al. A randomized clinical trial of a manual-guided risk reduction intervention for HIV-positive injection drug users. Health Psychol. 2003;22:223-228.
7. Rotheram-Borus MJ, Swendeman D, Comulada S, et al. Prevention for substance-using HIV-positive young people: telephone and in-person delivery. J Acquir Immune Defic Syndr. 2004;37(Suppl):S68-S77.
8. Samet JH, Horton NJ, Meli S, et al. A randomized controlled trial to enhance antiretroviral therapy adherence in patients with a history of alcohol problems. Antivir Ther. 2005;10:83-93.
9. Andrade ASA, McGruder HF, Wu A, et al. A programmable prompting device improves adherence to highly active antiretroviral therapy in HIV-infected subjects with memory impairment. Clin Infect Dis. 2005;41:875-882.
10. Remien RH, Stirratt MJ, Dolezal C, et al. Couple-focused support to improve HIV medication adherence: a randomized controlled trial. AIDS. 2005;19:807-814.
11. Knobel H, Carmona A, Lopez JL, et al. Adherence to very active antiretroviral treatment: impact of individualized assessment. Enferm Infecc Microbiol Clin. 1999;17:78-81.
12. Rathbun RC, Farmer KC, Stephens JR, et al. Impact of an adherence clinic on behavioral outcomes and virologic response in treatment of HIV infection: a prospective, randomized, controlled pilot study. Clin Ther. 2005;27:199-209.
13. Simoni JM, Pantalone DW, Frick P, et al. Enhancing antiretroviral adherence: a review of published reports of randomized controlled trials and ongoing NIH-funded research. In: Trafton JA, Gordon W, eds. Best Practices in the Behavioral Management of Chronic Disease. 2nd ed. Los Altos, CA: Institute for Disease Management; 2005:70-95.
14. Milam J, Richardson JL, McCutchan A, et al. Effect of a brief antiretroviral adherence intervention delivered by HIV care providers. J Acquir Immune Defic Syndr. 2005;40:356-363.
15. Mitty JA, Mwamburi DM, Macalino GE, et al. Improved virologic outcomes and less HIV resistance for HAART-experienced substance users receiving modified directly observed therapy (MDOT): results from a randomized controlled trial. Presented at: 13th Conference on Retroviruses and Opportunistic Infections; 2006; Denver.
16. Goldie SJ, Paltiel AD, Weinstein MC, et al. Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection. Am J Med. 2003;115:632-641.
17. Giordano TP, Visnegarwala F, White AC Jr, et al. Patients referred to an urban HIV clinic frequently fail to establish care: factors predicting failure. AIDS Care. 2005;17:773-783.
18. Gardner LI, Metsch LR, Anderson-Mahoney P, et al. Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care. AIDS. 2005;19:423-431.
19. Gandelman A, Rietmeijer CA. Translation, adaptation, and synthesis of interventions for persons living with HIV: lessons from previous HIV prevention interventions. J Acquir Immune Defic Syndr. 2004;37(Suppl):S126-S129.
20. Centers for Disease Control and Prevention. Diffusion of effective behavioral interventions for HIV prevention. Available at: http://www. effectiveinterventions.org. Accessed May 12, 2006.
21. Stover J, Bertozzi S, Gutierrez JP, et al. The global impact of scaling up HIV/AIDS prevention programs in low- and middle-income countries. Science. 2006;311:1474-1476.
22. Valdiserri RO. International scale-up for antiretroviral treatment: where does prevention fit? J Acquir Immune Defic Syndr. 2004;37(Suppl):S138-S141.
23. Maintaining anti-AIDS commitment post "3 by 5." Lancet. 2005;366:1828.
24. Nachega JB, Stein DM, Lehman DA, et al. Adherence to antiretroviral therapy in HIV-infected adults in Soweto, South Africa. AIDS Res Hum Retroviruses. 2004;20:1053-1056.
25. Byakika-Tusiime J, Oyugi JH, Tumwikirize WA, et al. Adherence to HIV antiretroviral therapy in HIV-positive Ugandan patients purchasing therapy. Int J STD AIDS. 2005;16:38-41.
26. Farmer P, Leandre F, Mukherjee JS, et al. Community-based approaches to HIV treatment in resource-poor settings. Lancet. 2001;358:404-409.
27. Koenig SP, Leandre F, Farmer PE. Scaling-up HIV treatment programmes in resource-limited settings: the rural Haiti experience. AIDS. 2004;18(Suppl):S21-S25.
28. Sarna A, Luchters S, Geibel S, et al. A randomized controlled trial evaluating a directly administered antiretroviral therapy (DAART) intervention to promote adherence to ART in Mombasa, Kenya. Presented at: NIMH/IAPAC International Conference on HIV Treatment Adherence; 2006; Newark.
29. Behforouz HL, Farmer PE, Mukherjee JS. From directly observed therapy to accompagnateurs: enhancing AIDS treatment outcomes in Haiti and in Boston. Clin Infect Dis. 2004;38(Suppl):S429-S436.
30. Paltiel AD. Cost-effectiveness of adherence interventions in HIV. Presented at: NIMH/IAPAC International Conference on HIV Treatment Adherence; 2006; Newark.
31. Elise A, France AM, Louise WM, et al. Assessment of adherence to highly active antiretroviral therapy in a cohort of African HIV-infected children in Abidjan, Cote d'Ivoire. J Acquir Immune Defic Syndr. 2005;40:498-500.
32. Pierre RB, White YRG, Steel-Duncan J. Adherence to antiretroviral drug therapy in children with HIV/AIDS in Jamaica. Presented at: NIMH/IAPAC International Conference on HIV Treatment Adherence; 2006; Newark.
33. Mugyenyi P. Advancing HIV treatment and adherence in Africa. Presented at: NIMH/IAPAC International Conference on HIV Treatment Adherence; 2006; Newark.